Drug Type Small molecule drug |
Synonyms 7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Ceftizoxime, Ceftizoxime sodium (JP17/USP) + [7] |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (15 Sep 1983), |
Regulation- |
Molecular FormulaC13H13N5NaO5S2 |
InChIKeyLNJZODVQDGCASS-LIGXYSTNSA-N |
CAS Registry68401-82-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00923 | Ceftizoxime Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Bronchitis | JP | 01 Jul 1986 | |
Cystitis | JP | 01 Jul 1986 | |
Pneumonia | JP | 01 Jul 1986 | |
Pyelonephritis | JP | 01 Jul 1986 | |
Bacterial Infections | US | 15 Sep 1983 |